Quetiapine is used for: Schizophrenia; Bipolar disorder; Major depressive disorder.
Recorded in the NepalDoc medicine catalog for Quetiapine.
Quetiapine is an atypical antipsychotic indicated for the treatment of: Schizophrenia, Bipolar I disorder manic episodes, Bipolar disorder, depressive episodes 1.1 Schizophrenia Quetiapine is indicated for the treatment of schizophrenia. The efficacy of quetiapine in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13 to 17 years).
From the U.S. FDA-approved label for Quetiapine. Full label: DailyMed.
Quetiapine is an atypical antipsychotic indicated for the treatment of: Schizophrenia, Bipolar I disorder manic episodes, Bipolar disorder, depressive episodes 1.1 Schizophrenia Quetiapine is indicated for the treatment of schizophrenia. The efficacy of quetiapine in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13 to 17 years). The effectiveness of quetiapine for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials. 1.2 Bipolar Disorder Quetiapine is indicated for the acute treatment of manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex. Efficacy was established in two 12-week monotherapy trials in adults, in one 3-week adjunctive trial in adults, and in one 3-week monotherapy trial in pediatric patients (10 to 17 years). Quetiapine is indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder.
From the U.S. FDA-approved label for Quetiapine. Full label: DailyMed.
2 DOSAGE & ADMINISTRATION, Quetiapine tablets, USP can be taken with or without food Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex 50 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Children and Adolescents (10 to 17 years), Monotherapy 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults 50 mg once daily at bedtime 300 mg/day 300 mg/day…
Directions from the U.S. FDA-approved label for Quetiapine — your doctor or pharmacist may advise differently.
Hypersensitivity to quetiapine or to any excipients in the quetiapine formulation. Anaphylactic reactions have been reported in patients treated with quetiapine. Known hypersensitivity to quetiapine or any components in the formulation.
Excerpt from the U.S. FDA-approved label for Quetiapine. Talk to a pharmacist or doctor before use.
Cerebrovascular Adverse Reactions: Increased incidence of cerebrovascular adverse events, (e.g., stroke, transient ischemic attack) has been seen in elderly patients with dementia related psychoses treated with atypical antipsychotic drugs, Neuroleptic Malignant Syndrome (NMS): Manage with immediate discontinuation and close monitoring, Metabolic Changes: Atypical antipsychotics have been associated with metabolic changes., These metabolic changes include hyperglycemia, dyslipidemia, and weight gain, Hyperglycemia and Diabetes Mellitus: Monitor patients for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness.
Warnings and precautions excerpt from the U.S. FDA-approved label for Quetiapine — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in more detail in other sections of the labeling: Increased mortality in elderly patients with dementia-related psychosis, Cerebrovascular adverse reactions, including stroke in elderly patients with dementia-related psychosis, Neuroleptic Malignant Syndrome (NMS), Metabolic changes (hyperglycemia, dyslipidemia, weight gain), Tardive dyskinesia, Hypotension, Falls, Increases in…
Excerpt from the U.S. FDA-approved label for Quetiapine — not a complete list. Talk to a pharmacist or doctor about side effects.
25 brands · 7 makers in the NepalDoc catalog — see the full Quetiapine guide →
Store at 25°C (77°F);
Storage information from the U.S. FDA-approved label for Quetiapine.
What is Qutipin SR?
Qutipin SR 50mg Tablet is a Quetiapine medicine made by Sun Pharmaceutical Industries Ltd. It comes as 50mg Tablet.
What is Qutipin SR used for?
Quetiapine is used for Schizophrenia, Bipolar disorder, Major depressive disorder.
What is the generic name of Qutipin SR?
The generic name of Qutipin SR is Quetiapine.
Which brands of Quetiapine are available in Nepal?
25 brands of Quetiapine are listed in the NepalDoc catalog, from 7 makers — including Psyquit -100mg Tablet, Psyquit -200mg Tablet, Psyquit -50mg Tablet, Psyquit-25mg Tablet, Q-mind 300 mg Tablet, Q-Mind SR 200mg Tablet.
What are the side effects of Quetiapine?
The following adverse reactions are discussed in more detail in other sections of the labeling: Increased mortality in elderly patients with dementia-related psychosis, Cerebrovascular adverse reactions, including stroke in elderly patients with dementia-related psychosis, Neuroleptic Malignant Syndrome (NMS), Metabolic changes (hyperglycemia, dyslipidemia, weight gain), Tardive dyskinesia, Hypotension, Falls, Increases in…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
